1. Most Discussed
  2. Gainers & Losers
MYX 98.5¢

News: Mayne expands US business

  1. Mayne Pharma Group Limited (ASX:MYX) have announced a new acquisition and a capital raising .
    The drug developer has entered an agreement to buy the Doryx brand from Actavis for around $64 million. The deal is expected to complete by the end of this month ahead of a two month transition period for the transfer of the business to Mayne Pharma.
    Doryx is a proven acne medication which has produced net revenues of $76 million in the 12 months to December and is expected to be immediately accretive. 
    Mayne has also expanded it US Speciality Brands division appointing three key staff already familiar with the Doryx brand. 
    Other smaller agreements to purchase ADD treatments have also been made. 
    The deals will be funded by a fully underwritten $115 million equity raising with the company to remain in a trading halt until Wednesday. 
    Mayne Pharma Group Limited (ASX:MYX) reported a net profit of $21.3 million for the 2014 financial year. 

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.